Archives: Speakers

Asad heads up the life science business globally for Volt International. He specialises in helping companies with their staffing needs across the globe on a permanent and contract basis.

Asad has over 105 recommendations on LinkedIn from various VP’s, Head’s & Directors of Clinical at Biotech, Clinical Stage, Pharmaceutical & CRO companies across the globe.

Vertical Expertise:

Clinical Operations, Clinical Research, Clinical Affairs & Clinical Development.

Client’s Expertise:

Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Clinical Research Organisations, Clinical Stage Biopharma Companies & Start Up Patient Recruitment Companies.

https://www.linkedin.com/in/asadbalal/

Boris Rankov leads the AI product strategy and front office solutions suite for InvestCloud, shaping next-generation capabilities for wealth managers worldwide. Prior to InvestCloud, Boris co-founded the Swiss AI wealth tech InCube Group, serving as Chief Product Officer, and guided the company from inception through growth to its acquisition and full integration into the InvestCloud global platform. A PhD graduate in electrical engineering from ETH Zurich, Boris has spent more than 20 years at the intersection of finance, AI, and advanced analytics, and is a frequent speaker and author on the application of AI to wealth management.

Sylvain joined the London Stock Exchange Group through the acquisition of Beyond Ratings in 2019, a Climate and ESG data, and research firm that he co-founded in 2014. Sylvain is the global head of Sustainable Investment product management, covering the indexes, data and analytics business lines, across asset classes and geographies.

Sylvain has an extensive experience in the business intelligence industry. Previously Sylvain was the CEO of Enerdata, a data and research company specialized in the energy and carbon markets.

Chiara Gelmini is a passionate thought leader and strategist focusing on financial services institutions and, particularly, on client lifecycle management. Chiara brings over 10 years of experience working in the following sectors: private banking, wealth management, retail banking, and regulatory compliance. She drives and oversees all aspects of marketing and communications for Appway’s wealth management offering which covers the full client lifecycle. In her time at Appway, Chiara covered the role of Business Practice Manager, driving business-side development of the Appway Solutions portfolio, and served as Business Consultants Function Lead, raising and leading the Appway Business Consultants global team and overseeing the Appway consulting methodology tools from conception to evolution. Prior to joining Appway, Chiara served as Front and Compliance officer for an international external asset manager based in Switzerland

I studied Computer Science at the Swiss Federal Institute of Technology in Zürich (ETHZ) obtaining the Computer Science diploma in 1992. A few years later, in 2002, I completed a Master’s degree in Business Administration (MBA) and in 2017 I obtained the OpenGroup certification as Master Certified Architect. Professionally I have about 30 years of experience in the software IT industry and in particular into the financial sector. I have worked for banks, a worldwide leading data and software provider and leading banking outsourcing companies in Switzerland. After a long and mainly technical professional experience, I have covered various managerial roles and responsibilities in departments dealing with business and technology architecture at 360 degrees in the banking sector, with a particular focus on wealth & asset management.

Experienced biopharmaceutical executive with more than 20 years of clinical drug development and medical affairs experience in small to large pharmaceutical and biotechnology companies. I currently apply my scientific knowledge and experience to the development of molecules modulating the Wnt pathway.

Trudy served on the board of Insys Therapeutics from April 2018-February 2020 and is open to new board positions that leverage her R&D and corporate development experience.

Toby Odenheim is the former Director of Technology and Governance at the Parker Institute for Cancer Immunotherapy (PICI). He is now Senior Vice President, Research & Development Technology at ProPharma Group.

Committed to accelerating the development of new medical treatments through effective technology adoption and continual process improvement.

Nanomed, with the headquarter at Cupertino, CA, applies innovative microfabrication technology to make a delivery tool for skincare actives. This is a new way of overcoming skin barrier and delivering actives without needle injection.

The product successfully went through two clinical trials and got into the finals of Asian Innovation Award together with IBM Healthsolution Lab’s product sponsored by the Wall Street Journal and won Silver Prize in 2010.

Nanomed’s antiblemish product was successfully launched at AAD, the largest dermatology annual meeting in US. Together with Sephora’s product, Nanomed’s delivery product got into the top three for the International Package Design Award (tool category) at 2012 HBA Global in New York City.